These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22157050)

  • 21. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG uptake in obturator internus as an indicator of diarrhea.
    Ozawa N; Okamura T; Koyama K; Noda M; Inoue Y
    Clin Nucl Med; 2007 Jul; 32(7):540-2. PubMed ID: 17581340
    [No Abstract]   [Full Text] [Related]  

  • 23. [False positive (18)F-FDG PET/CT uptake by fat necrosis during chemotherapy for malignant lymphoma].
    Akiyama H; Umezawa Y; Nakamura Y; Kumagai T
    Rinsho Ketsueki; 2013 Jan; 54(1):127-9. PubMed ID: 23391657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. False-positive uptake on 2-[¹⁸F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging.
    Culverwell AD; Scarsbrook AF; Chowdhury FU
    Clin Radiol; 2011 Apr; 66(4):366-82. PubMed ID: 21356398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign causes of 18-FDG uptake on whole body imaging.
    Bakheet SM; Powe J
    Semin Nucl Med; 1998 Oct; 28(4):352-8. PubMed ID: 9800240
    [No Abstract]   [Full Text] [Related]  

  • 27. GLUT1 expression in tissue and (18)F-FDG uptake.
    Avril N
    J Nucl Med; 2004 Jun; 45(6):930-2. PubMed ID: 15181126
    [No Abstract]   [Full Text] [Related]  

  • 28. FDG PET appearance of a postpartum uterus.
    Lin E
    Clin Nucl Med; 2006 Mar; 31(3):159-60. PubMed ID: 16495738
    [No Abstract]   [Full Text] [Related]  

  • 29. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty.
    Zhuang H; Chacko TK; Hickeson M; Stevenson K; Feng Q; Ponzo F; Garino JP; Alavi A
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1328-33. PubMed ID: 12271415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of physiologic uptake detected with true whole-body 18F-FDG PET/CT in healthy subjects.
    Reinking MF; Osman MM
    J Nucl Med Technol; 2009 Mar; 37(1):31-7. PubMed ID: 19223428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal carcinomatosis: role of (18)F-FDG PET.
    Turlakow A; Yeung HW; Salmon AS; Macapinlac HA; Larson SM
    J Nucl Med; 2003 Sep; 44(9):1407-12. PubMed ID: 12960184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
    Basu S; Houseni M; Alavi A
    Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal F-18 FDG uptake in two epidermoid cysts on PET/CT.
    Bybel B; Leslie WD
    Clin Nucl Med; 2009 Dec; 34(12):918-9. PubMed ID: 20139834
    [No Abstract]   [Full Text] [Related]  

  • 34. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent FDG uptake around an inguinal mesh prosthesis 25 years after implantation.
    Koljevic-Markovic A; Orcurto MV; Doenz F; Delaloye AB; Prior JO
    Clin Nucl Med; 2007 Mar; 32(3):242-3. PubMed ID: 17314611
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy].
    Chen YR; Li WX; Lin YR; Chen LH
    Ai Zheng; 2004 Oct; 23(10):1210-2. PubMed ID: 15473938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (18)F-FDG PET/CT of adrenal lesions.
    Dong A; Cui Y; Wang Y; Zuo C; Bai Y
    AJR Am J Roentgenol; 2014 Aug; 203(2):245-52. PubMed ID: 25055255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscular FDG uptake after chewing chewing gum in a patient with Hodgkin disease.
    Vock J; Juengling FD; Krause T; Wissmeyer M
    Clin Nucl Med; 2007 Feb; 32(2):124-7. PubMed ID: 17242567
    [No Abstract]   [Full Text] [Related]  

  • 39. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer.
    Iguchi T; Matsuoka J; Sato S; Okumura Y; Omori M; Mifune H; Akaki S; Kanazawa S
    Clin Nucl Med; 2007 May; 32(5):361-2. PubMed ID: 17452862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.